Cargando…

Detection of Anti-SARS-CoV-2 Nucleocapsid and Spike Antibodies in Patients with Coronavirus Disease 2019 in Japan

OBJECTIVES: Coronavirus Disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Serological testing for anti-SARS-CoV-2 nucleocapsid (N) antibodies (Abs) and anti-SARS-CoV-2 spike (S) Abs is performed to detect prior COVID-19 infection. It is still cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Furukawa, Hiroshi, Oka, Shomi, Higuchi, Takashi, Yamaguchi, Miho, Uchiyama, Shota, Koiwa, Tomohiro, Nakama, Moriyuki, Minegishi, Masaaki, Nagai, Hideaki, Tohma, Shigeto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990541/ https://www.ncbi.nlm.nih.gov/pubmed/35401020 http://dx.doi.org/10.1177/11795484221075492

Ejemplares similares

Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese
por: Midorikawa, Rie, et al.
Publicado: (2022)

Anti-SARS-CoV-2 Spike Antibody Titers and Neutralizing Antibodies in Vaccinated Rheumatoid Arthritis Patients
por: Furukawa, Hiroshi, et al.
Publicado: (2022)

Associations of HLA Polymorphisms with Anti-SARS-CoV-2 Spike and Neutralizing Antibody Titers in Japanese Rheumatoid Arthritis Patients Vaccinated with BNT162b2
por: Higuchi, Takashi, et al.
Publicado: (2023)

Lack of Association of rs12702634 in RPA3-UMAD1 With Interstitial Lung Diseases in Japanese Rheumatoid Arthritis Patients
por: Higuchi, Takashi, et al.
Publicado: (2022)

Genetic risk factors for autoimmune hepatitis: implications for phenotypic heterogeneity and biomarkers for drug response
por: Higuchi, Takashi, et al.
Publicado: (2021)

Biomarkers for interstitial lung disease and acute-onset diffuse interstitial lung disease in rheumatoid arthritis
por: Furukawa, Hiroshi, et al.
Publicado: (2021)

False-positive detection of IgM anti-severe acute respiratory syndrome coronavirus 2 antibodies in patients with rheumatoid arthritis: Possible effects of IgM or IgG rheumatoid factors on immunochromatographic assay results
por: Oka, Shomi, et al.
Publicado: (2022)

Genetics of Interstitial Lung Disease: Vol de Nuit (Night Flight)
por: Furukawa, Hiroshi, et al.
Publicado: (2015)

Associations of HLA Polymorphisms with Chronic Kidney Disease in Japanese Rheumatoid Arthritis Patients
por: Higuchi, Takashi, et al.
Publicado: (2023)

Serum biomarker analysis of collagen disease patients with acute-onset diffuse interstitial lung disease
por: Oka, Shomi, et al.
Publicado: (2013)

Role of Deleterious Rare Alleles for Acute-Onset Diffuse Interstitial Lung Disease in Collagen Diseases
por: Furukawa, Hiroshi, et al.
Publicado: (2019)

Plasma miRNA expression profiles in rheumatoid arthritis associated interstitial lung disease
por: Oka, Shomi, et al.
Publicado: (2017)

Serum Metabolomic Profiles of Rheumatoid Arthritis Patients With Acute-Onset Diffuse Interstitial Lung Disease
por: Furukawa, Hiroshi, et al.
Publicado: (2019)

Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis
por: Oka, Shomi, et al.
Publicado: (2022)

Antibodies against Serum Anti-Melanoma Differentiation-Associated Gene 5 in Rheumatoid Arthritis Patients with Chronic Lung Diseases
por: Oka, Shomi, et al.
Publicado: (2023)

Association of a FAM13A variant with interstitial lung disease in Japanese rheumatoid arthritis
por: Higuchi, Takashi, et al.
Publicado: (2023)

Predisposition of HLA-DRB1*04:01/*15 heterozygous genotypes to Japanese mixed connective tissue disease
por: Oka, Shomi, et al.
Publicado: (2022)

Association of a Single Nucleotide Variant in TERT with Airway Disease in Japanese Rheumatoid Arthritis Patients
por: Higuchi, Takashi, et al.
Publicado: (2023)

HLA-DRB1*08:02 Is Associated with Bucillamine-Induced Proteinuria in Japanese Rheumatoid Arthritis Patients
por: Furukawa, Hiroshi, et al.
Publicado: (2014)

Serum Metabolomic Profiling in Rheumatoid Arthritis Patients With Interstitial Lung Disease: A Case–Control Study
por: Furukawa, Hiroshi, et al.
Publicado: (2020)

Antibody responses to SARS-CoV-2 nucleocapsid and spike proteins in hospitalized patients with COVID-19: A multicenter, retrospective, cross-sectional study in Japan
por: Hibino, Makoto, et al.
Publicado: (2022)

Autoantibody Profiles in Collagen Disease Patients with Interstitial Lung Disease (ILD): Antibodies to Major Histocompatibility Complex Class I-Related Chain A (MICA) as Markers of ILD
por: Furukawa, Hiroshi, et al.
Publicado: (2015)

Association of HLA-DRB1 genotype with younger age onset and elder age onset rheumatoid arthritis in Japanese populations
por: Oka, Shomi, et al.
Publicado: (2019)

Association of Increased Frequencies of HLA-DPB1*05∶01 with the Presence of Anti-Ro/SS-A and Anti-La/SS-B Antibodies in Japanese Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients
por: Furukawa, Hiroshi, et al.
Publicado: (2013)

Antibody detection of SARS-CoV spike and nucleocapsid protein
por: Chang, Mau-Sun, et al.
Publicado: (2004)

Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen
por: Dobaño, Carlota, et al.
Publicado: (2022)

α5β1 integrin induces the expression of noncartilaginous procollagen gene expression in articular chondrocytes cultured in monolayers
por: Tanaka, Nobuho, et al.
Publicado: (2013)

Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays
por: Rikhtegaran Tehrani, Zahra, et al.
Publicado: (2020)

Identification of Conserved Epitopes in SARS-CoV-2 Spike and Nucleocapsid Protein
por: Forcelloni, Sergio, et al.
Publicado: (2021)

Protective Effect of the HLA-DRB1*13:02 Allele in Japanese Rheumatoid Arthritis Patients
por: Oka, Shomi, et al.
Publicado: (2014)

Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in the spike 2 domain and the nucleocapsid protein of feline infectious peritonitis virus
por: Satoh, Ryoichi, et al.
Publicado: (2011)

Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic Assays
por: Tehrani, Zahra Rikhtegaran, et al.
Publicado: (2020)

Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America
por: Franco-Muñoz, Carlos, et al.
Publicado: (2020)

Computational studies of the dynamics of SARS-CoV-2 spike, membrane, and nucleocapsid proteins
por: Dutta, Mandira, et al.
Publicado: (2022)

Assessment of immunoglobin G (spike and nucleocapsid protein) response to COVID-19 vaccination in Palestine
por: Asmar, Imad, et al.
Publicado: (2023)

Human post‐infection serological response to the spike and nucleocapsid proteins of SARS‐CoV‐2
por: Xiao, Cheng, et al.
Publicado: (2020)

Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity
por: Lee, Eunok, et al.
Publicado: (2021)

Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2
por: Dangi, Tanushree, et al.
Publicado: (2021)

Nucleocapsid and Spike Proteins of SARS-CoV-2 Drive Neutrophil Extracellular Trap Formation
por: Youn, Young-Jin, et al.
Publicado: (2021)

Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms
por: Varnai, Reka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_he4t6ft0tmlvao38gd4hbf21bc